Adcock Ingram Integrated Report 2018

ANNUAL FINANCIAL STATEMENTS Notes to the Group annual financial statements continued 76 ADCOCK INGRAM  Integrated Report 2018 2 DISCONTINUED OPERATIONS Adcock Ingram Private Limited (India) and 53.47% of Ayrton Drug Manufacturing Limited (Ayrton) in Ghana were disposed of on 14 October 2016 and 7 December 2016 respectively. The loss of control on disposal resulted in the foreign currency translation reserve relating to both entities being recycled to profit and loss during the previous financial year. 2017 R'000 2.1 STATEMENT OF COMPREHENSIVE INCOME REVENUE 120 174 TURNOVER 118 901 Cost of sales (47 191) Gross profit 71 710 Selling, distribution and marketing expenses (39 077) Fixed and administrative expenses (17 384) Trading profit 15 249 Non-trading expenses (6 833) Operating profit 8 416 Finance income 1 273 Finance costs (2 014) Profit before taxation 7 675 Taxation (1 301) Profit for the period from discontinued operations 6 374 Profit on disposal of the discontinued operations 34 758 Profit for the period from discontinued operations 41 132 Profit/(loss) attributable to: India 46 638 Ayrton (5 506) 41 132 Profit attributable to: Owners of the parent 39 903 Non-controlling interests 1 229 41 132 2.2 CASH INFLOW ON DISPOSAL Consideration received 338 601 India 327 565 Ayrton 11 036 Net cash disposed of with the discontinued operations (47 505) India (48 807) Ayrton 1 302 Net cash inflow 291 096